The Granulation Process 101: Basic Technologies for Tablet Making

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-01-2002
Volume 2002 Supplement
Issue 2

The author offers a primer for choosing the correct granulation process to improve yields, reduce tablet defects, and enhance productivity.

External Link - article-36208.pdf

Articles in this issue
Roller Compaction Feasibility for New Drug Candidates: Laboratory to Production Scale
The Granulation Process 101: Basic Technologies for Tablet Making
Evaluating the Elastic Behavior of Pharmaceutical Excipients and Binary Mixtures Using the Modified Fraser-Suzuki Function
Recent Videos
Drug Digest: Patient Preference Drives Solid Dosage Trends
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Related Content
The mRNA or messenger Ribonucleic Acid white text for medical or outbreak concept 3d rendering | Image Credit: ©niphon - adobe.stock.com

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

Cheryl Barton
June 24th 2025
Article

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

AstraZeneca and Alteogen Sign License Agreement for Developing Subcutaneous Formulations of Oncology Assets

Feliza Mirasol
March 25th 2025
Article

Under the agreement, AstraZeneca will use Alteogen’s proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.

Drug Solutions Podcast: mRNA Past, Present, and Future

Drug Solutions Podcast: mRNA Past, Present, and Future

Chris Spivey
August 17th 2023
Podcast

An mRNA conversation about the recent past, current hot topics, and probable future.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Approves Evrysdi Tablet from Roche for Spinal Muscular Atrophy

Feliza Mirasol
February 17th 2025
Article

The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.

Two dosing pens of a fictitious semaglutide drug (GLP-1) on a scale facing a dumbbell. Concept for alternative ways to loose weight. | Image Credit: © Andreas Prott - Stock.adobe.com

Next-Generation Anti-Obesity Medicines

Cheryl Barton
February 8th 2025
Article

European biopharma companies are looking beyond GLP-1s.